JournalofClinicalNeuroscience(2003)10(5),553–556
0967-5868/$-seefrontmatterª2003ElsevierScienceLtd.Allrightsreserved.
doi:10.1016/S0967-5868(02)00305-3
Clinical study
Intracranial meningioma and breast cancer
Ann-Shung Lieu,Shih-LinHwang, Shen-Long Howng
DepartmentofNeurosurgery,KaohsiungMedicalUniversityHospital,Kaohsiung,Taiwan
Summary Breast carcinoma has a high predisposition to metastasize to the brain parenchyma. An association between carcinoma of the
breastandintracranialmeningiomahasbeenreported.Theavailablepublishedarticlesregardingpatientswithintracranialmeningiomaand
breastcarcinomahavebeenreviewed.Tothebestofourknowledge,86casesincludingour4caseshavesofarbeenreported.Allcaseswere
female,andthemeanagewas62.4yearswhenintracranialmeningiomawasdiagnosed.Themeanintervalofthe2tumourswas4.5years.
Twenty-fivecasesofbreasttumourwereinfiltratingductcarcinomas.Thelocationofintracranialmeningiomaandpathologicsubtypeshowed
nospecificpredominance.Hormonereceptor studywas performedin28cases.Inmeningioma, the positiverateofprogesteronereceptor
(32.1%)ishigherthanoestrogenreceptor(7.1%);whilethepositiverateofoestrogenreceptor(53.6%)ishigherthantheprogesteronereceptor
(42.9%)inbreastcancer.Areviewofthisstudyispresentedwithemphasisontheexistenceofintracranialmeningiomaandbreastcancerin
onepatientatdifferentperiods.Lesionsofthecentralnervoussysteminpatientswithbreastcancershouldnotbeimmediatelylabeledas
metastases.Intracranialmeningiomashouldbeexcluded.Likewise,patientswithmeningiomashouldhaveperiodicphysicalexaminationsand
mammographieswherebydiseasemaybediagnosedandtreatedatanearlystage.
ª 2003ElsevierScienceLtd.Allrightsreserved.
Keywords:intracranialmeningioma,breastcancer
INTRODUCTION mitted for progressive dizziness and vomiting. Brain computed
tomography(CT) withoutcontrast mediumenhancement showed
Breastcarcinomaisconsideredacommonmalignantneoplasmin
one isodense mass with calcification in the cerebellopontine
women. Patients with a history of breast carcinoma develop
angle. Infusion of contrast medium, revealed homogenous en-
neurologicalsymptomsandsigns.Frequently,theyareconsidered
hancement. Brain magnetic resonance imaging was performed
to have brain metastases and submitted to radiotherapy, quite
which raised suspicion of a meningioma. Craniectomy was
often without any further investigation. However, multiple pri-
performed with total removal of the tumour, which was subse-
marytumours,benignormalignant,coexistinginthesamepatient
quently reported as psammomatous type of meningioma by
occur with a frequency of 2.8% in patients with neoplasms.1–3
pathologic studies. Oestrogen and progesterone receptor study
Meningiomas represent 20% of all central nervous system tu-
were negative.
moursand are encounteredtwice as often inwomen asinmen.4
The existence of breast carcinoma and meningioma was sug-
gested by Schoenberg etal. in 1975.5 An awareness of this exis- Case2
tence,withmoderntechniquesofinvestigation,maypermitmore
This 60 year old women was admitted to our hospital in May
cases to be diagnosed and treated earlier. Herein, we present 4
1996, complaining of progressive weakness in her left limbsand
cases of intracranial meningioma and breast carcinoma, and a
unstable gait. Ten years prior, she underwent a left mastectomy
comprehensive reviewof thesubject.
for carcinoma of the breast. During hospitalization, brain CT
scans demonstrated a well-defined mass in the right temporal
MATERIALS ANDMETHODS regionwithmoderateperifocaloedema.Aftercontrastmedium,it
During theperiod fromJanuary1986toMay 1999,there were 4 revealed homogenous enhancement. Craniotomy with total re-
cases of intracranial meningioma associated with breast carci- moval of tumour was performed. Histopathologic examination
noma,outofaseriesof246intracranialmeningiomasoperatedon revealed it to be meningotheliomatous type. Oestrogen and pro-
attheKaohsiung Medical University. gesteronereceptorassaywasdone.Theresultsshowedapositive
responseofprogesterone; and,negative ofoestrogen.
Case1
A 40 year old woman underwent a left modified radical mas- Case3
tectomy in February 1996 for carcinoma of breast. Hormonal This42yearoldwomansufferedfromfocalseizureofrightlower
receptor studies were positive for estrogen and progesterone limb. Brain CTscans showed a well-defined mass in theleft pa-
receptors. Following surgery, the patient received adjuvant che- rietalregionwithsevereperifocaloedemaandfocalcalcification.
motherapy and radiotherapy. In October 1998, she was read- Homogenous enhancement was noted after infusion of contrast
medium.Acraniotomywasperformedwithtotalremovalofafalx
meningioma. The pathologic study demonstrated a meningiothe-
Received30July2002 liomatous meningioma. Progesterone receptor test was positive,
Accepted31October2002 andtheestrogenreceptorwasnegative.Fouryearsand5months
later,shewasfoundtohaveahardmassintheleftbreast.Biopsy
Correspondenceto:Shen-LongHowngMDPhD,Departmentof
showed infiltrating duct carcinoma. A modified radical mastec-
Neurosurgery,KaohsiungMedicalUniversityHospital,No.100,Shih-Chuan
1stRoad,KaohsiungCity807,Taiwan.Tel.:+886-7-3215049; tomywasdoneandnegativenodeswerefound.Sheisdoingwell
Fax:+886-7-3215039. 13years aftercraniotomy.
553
554 Lieuetal.
Case4 DISCUSSION
A 46 year old woman with a mass in the left breast had a Between January 1986 and May 1999, 1853 patients with breast
modified radical mastectomy after biopsy, showing infiltrating cancer underwent surgery in Kaohsiung Medical University.
ductal carcinoma. All nodes were negative. Eight years later, Duringthisperiod,246patientsunderwentsurgeryforintracranial
she began exhibiting poor memory and bizarre behavior which meningioma, giving a 1 to 7.5 ratio between intracranial menin-
was reported by her family. Brain CT scans showed a huge giomaandbreastcancer,whichisaconsiderablyhigherratethan
mass with perifocal oedema in the left frontal region. After thatreportedbyBurnsetal.6 andSmithetal.7 Theinterestinthe
infusion of contrast medium, it showed homogenous enhance- existence of both breast cancer and meningioma is raised by the
ment. Bone window showed left frontal hyperostosis. A cra- clinicalrelevanceofanintracranialtumourdiscoveredinapatient
niotomy was performed with total excision of the tumour. withhistoryofbreastcancerandtheneedtodifferentiateitfroma
Pathologic examination demonstrated a meningiotheliomatous metastasis.8;9;10
meningioma. Oestrogen and progesterone receptor assay Published articles were reviewed and they revealed 82 case
showed negative study. She had an uneventful postoperative reports of patients with both breast cancer and meningioma, to
recovery. which we have added 4 cases. The clinical details of these are
Table 1 Clinicaldataofpatientswithbreastcancerandmeningiomas:LiteratureReview
Authors Ageatdiagnosisof Sitemeningioma Breastcancer Meningioma Intervalbetween
meningioma(years) type type tumours(years)
Markopoulosetal.11 45(1) Convexity NC NC 0.8
Salvati12 52.8(cid:1)(9) Convexity(3) AllIDC Transitional(5) 4.1(cid:1)
Sphenoidridge(6) Psammomatous(2)
Meningotheliomatous(2)
Cervonietal.13 65(1) Falx ILC Fibroblastic <0.1
DiBonitoetal.8 74.9(cid:1)(12) Vault(6) IDC(9) Psammomatous(7) Unknown
Convexity(2) ILC(2) Transitional(4)
Parasellar(1) NC(1) Meningotheliomatous(1)
Middlefossa(1)
Smith-Behn14 Unknown(2)
68.8(cid:1)(4) Olfactory(1) IDC(3) NC(4) 3.6(cid:1)
Unknown(3) NC(1)
Chowetal.15 50(1) Sphenoidridge NC Meningotheliomatous 8
Knuckeyetal.16 63.2(cid:1)(5) Convexity(2) NC(5) Fibroblastic(3) 5.8(cid:1)
Parasagittal(1) Psammomatous(1)
Posteriorfossa(1) Meningotheliomatous(1)
Middlefossa(1)
Rubinsteinetal.9 61.2(cid:1)(9) Convexity(5) NC(9) NC(9) 4.1(cid:1)
Multiple(2)
Suprasellar(1)
Parasagittal(1)
Zonetal.17 63(1) Convexity ILC NC 6
Doron3 64(1) Convexity NC Meningotheliomatous 3
Jacobetal.18 68.6(cid:1)(12) Sphenoidridge(5) NC NC 11.4(cid:1)
Unknown(7)
Burnsetal.6 56.4(cid:1)(5) Convexity(2) IDC(2) Meningiotheliomatous(2) 6.2(cid:1)
Suprasellar(1) NC(2) Mixed(2)
Sphenoidridge(1) Other(1) NC(1)
Unknown(1)
Mehtaetal.10 70(cid:1)(3) Olfactory(1) NC(3) NC(3) 2.2(cid:1)
Posteriorfossa(1)
Falx(1)
Barz19 56(1) Unknown NC Meningotheliomatous 2
Lodrini20 54(1) Olfactory NC Meningotheliomatous 1.2(cid:1)
Chamberetal.21 66(1) Unknown NC Psammomatous –
Savoiardo22 53(1) Olfactory NC Meningotheliomatous 1
Poo€yhoo€nenetal.23 79(1) Convexity NC Meningotheliomatous 2
Smith7 55(cid:1)(2) Parasagittal(1) IDC(2) NC(2) 5.8(cid:1)
Convexity(1)
Kepes24 52(1) Convexity NC Meningotheliomatous 2.5
Schoenbergetal.5 63.3(cid:1)(7) Unknown NC(7) NC(7) 7(cid:1)
Haar25 Middle(1) Convexity NC NC 2
Theologides26 74(1) Convexity Scirrhous Meningotheliomatous 0.2
Anlyanetal.27 42(1)
Raskind28 57(1) Sphenoidridge NC NC 7.2
Kuboetal.40 57(1) Parasagittal IDC Transitional 4
Present 49.5(cid:1)(4) Convexity(2) IDC(3) Meningotheliomatous(3) 6.3(cid:1)
Falx(1) Carcinoma Psammomatous(1)
Posteriorfossa(1) (1)
(cid:1)Mean.
IDC,infiltratingductalcarcinoma;ILC,infiltratinglobularcarcinoma;NC,noclassification;(),inauthors’line,itrepresentsreferencenumber,theothersrepresent
casenumber.
JournalofClinicalNeuroscience(2003)10(5),553–556 ª2003ElsevierScienceLtd.Allrightsreserved.
Intracranialmeningiomaandbreastcancer 555
Table 2 Differentialdiagnosisofintracranialmeningiomafrommetastaticbreastcarcinoma
Intracranialmeningioma Metastasis
SkullX-ray Hyperostosis Destruction
CT
Non-enhanced Isodenseorslightlyhyperdense Variable
Enhanced Well-definedmasswithhomogenousenhancement Well-definedmasswithheterogenousenhancement
andextensiveperifocaloedema
MRI
Non-enhanced T1-weighted:isointenseormildlyhypointense T1-weighted:hypointense
T2-weighted:isointenseormildlyhyperintensive T2-weighted:hyperintense
Enhanced Homogenousenhancementwithmeningealtail Heterogenousenhancement
summarisedinTable1.Themeanageofpresentationforpatients Jacobs et al.18 and Salvati et al.12 suggested sphenoidal ridge
with intracranial meningioma was 62.4 years, and mean age for meningiomas were more likely to be associated with breast can-
patients withbreast cancerwas56.2 years.This ageistypical of cer.However, in ourstudy theassociationwasnot apparent.
patients with either intracranial meningioma or breast cancer. Onsetandtypesofneurologicsymptomsandsignscannotbe
Breastcancerwasdiagnosedfirstin80.2%ofcasesandthemean used to distinguish between metastatic breast cancer and intra-
duration before the diagnosis of the second tumour, be it breast cranial meningioma, since they are similar. Brain CT scans and
cancer or intracranial meningioma, was 4.5 years. The longest magnetic resonance imaging (MRI) may be useful (Table 2). On
interval between tumour diagnoses was 29 years.18 The trend of brainCTscansandMRI,metastasisofthebreastcancershowsas
breastcancerpresentationfirst,whichisalsoreflectedin3ofour outward expansion of the gray/white matter junction (intra-axial
4 patients, may simply reflect the slow growth of intracranial lesion) rather than inward buckling by the intracranial meningi-
meningioma. The location of intracranial meningioma was as oma (extra-axial lesion). Extensive perifocal oedema is present
follows: convexity (23 cases), sphenoid ridge (15), parasagittal/ with metastasis, whereas this is not common in intracranial me-
falx(7),olfactory(4),others(18)andunknown(21).Thesubtype ningioma. Bone destruction is found in metastasis, but in intra-
of meningioma was as follows: meningotheliomatous (17), cranial meningioma, hyperostosis may be seen. On enhanced
psammomatous (12), transitional (10), fibroblastic (5), mixed (2) MRI, intracranial meningiomas undergo homogenous enhance-
andnoclassification(40).Thelocationandsubtypeofintracranial ment with linear enhancement along the dura adjacent to the tu-
meningioma revealed nospecific predominance. mour(meningeal“tail”).39
Breast cancer and meningioma share several features that In summary, intracranial meningioma and breast cancer usu-
mightaccountfortheirexistencein1patient.Fromepidemiologic allyoccurinthesameagegroups;therefore,thephysicianshould
survey, both tumours occur commonly in the same adult female beaware ofthepossibilityoftheexistence ofbothbreastcancer
population,usuallyinthefifthandsixthdecade;whichissimilar and intracranial meningioma. The findings of cerebral mass in a
to those in our review.4;29 From the viewpoint of clinical course, patient with breast cancer shouldnot definitively indicate metas-
intracranial meningioma express symptoms rapidly, with an in- tasis. Resectable intracranial meningioma should be diagnosed
crease in size during pregnancy and a complete clinical subsi- differentially. Likewise, patients with intracranial meningioma
dence postpartum.30;31 Ithas yet to be clarified as towhether the shouldhaveperiodicphysicalexaminationsandmammographies,
increase in size isdue toan expeditionof therate of growth,in- bywhichdiseasemaybediagnosedandtreatedatanearlystage.
fluenced by hormonal changes during pregnancy, or to an in-
creased fluid content, based on the generally increased water
retention duringpregnancy.5;11;30;31 REFERENCES
Breast cancer cells often express oestrogen and progesterone
receptors.32Inmeningioma,oestrogenreceptorshadbeendetected 1. MoetrelCG.Incidenceandsignificanceofmultipleprimaryneoplasms.AnnN
YAcadSci1961;114:886–895.
initially, but progesterone receptors were later documented in
2. LodriniS,SavoiardoM.Metastasesofcarcinomatointracranialmeningioma:
highertissueconcentration.33–35Infact,quantitativeassessmentof reportoftwocasesandreviewoftheliterature.Cancer1981;48:
these hormone receptors usually yielded twice as many proges- 2668–2673.
terone receptors as oestrogen receptors in meningiomas.34;36 In 3. DoronY,GruskiewiczJ.Metastasisofinvasivecarcinomaofthebreasttoan
extraduralmeningiomaofthecranialvault.Cancer1987;60:1081–1084.
breast cancer, thecytoplasmic progesteronereceptors are usually
4. Al-MeftyO.Meningiomas,firstedn.RavenPressLtd.,NewYork;1991:
elevatedwhencytoplasmicoestrogenreceptorsarepresentinhigh 27–35.
levels.17 Therefore, the hormone receptor status of meningioma 5. SchoenbergBS,ChristineBW,WhisnantJP.Nervoussystemneoplasmsand
appears to be different from that of breast cancer. This discrep- primarymalignanciesofothersides.Theuniqueassociationbetween
meningiomaandbreastcancer.Neurology1975;25:705–712.
ancy suggests a possible derangement of the normal cellular
6. BurnsPE,NareshJ,BainGO.Associationofbreastcancerwithmeningioma:a
hormonal control mechanism in meningioma.17 In our 4 menin-
reportoffivecases.Cancer1986;58:1537–1539.
gioma cases, progesterone receptor tests were positive in 2 pa- 7. SmithFP,SlavikM,MacDonaldJS.Associationofbreastcancerwith
tients,and oestrogenreceptor testswere allnegative.Amongthe meningioma:reportoftwocasesandreviewoftheliterature.Cancer1978;42:
86reviewed cases, includingour 4 cases,hormone receptor tests 1992–1994.
8. DiBonitoL,GiarelliG,falconieriD,Bonifacio-GoriG,VielhP.Associationof
were performed in 28cases. Regarding intracranial meningioma,
breastcancerandmeningioma:reportof12newcasesandreviewofthe
the progesterone receptor tests were positive in 9 cases (32.1%), literature.PathResPract1993;189:399–404.
andoestrogenreceptortestswerepositiveinonly2cases(7.1%). 9. RubinsteinAB,ScheinM,ReichenthalE.Theassociationofcarcinomaofthe
This incidence is similar to the report of Cahill et al.,34 but is breastwithmeningioma.SurgGynecolObstet1989;169:334–336.
lowerthanotherauthors’reports.35–38 Inbreastcancer,oestrogen 10. MethaD,KhatibR,PatelS.Carcinomaofthebreastandmeningioma.
AssociationofManagement.Cancer1983;51:1937–1940.
receptor positive rate (53.6%) is higher than the progesterone
11. MarkopoulosC,SampalisF,GivalosN,GogasH.Associationofbreastcancer
receptor rate (42.9%),butisof nosignificant difference. withmeningioma.EurJSurgOncol1998;24:332–334.
ª2003ElsevierScienceLtd.Allrightsreserved. JournalofClinicalNeuroscience(2003)10(5),553–556
556 Lieuetal.
12. SalvatiM,CervoniL.Associationofbreastcarcinomaandmeningioma: 28. RaskindR,WeissSR.Conditionssimulatingmetastaticlesionsofthebrain.
reportofninenewcasesandreviewoftheliterature.Tumori1996;82: Reportofeightcases.IntSurg1970;53:40–43.
491–493. 29. BarberH.ManualofGynecologicOncology.JBLippincott,Philadephia;1989.
13. CervoniL,SalvatiM,GagliardiD,DelfiniR.Metastasisofbreastcarcinomato Codio:12,491/abbi,1996.
intracranialmeningioma.Casereport.NeurosurgRev1994;17:233–236. 30. MichelsenJJ,NewPFJ.Braintumorandpregnancy.JNeurolNeurosurg
14. Smith-BehnJ.Relationshipbetweenbreastcancerandmeningioma.SouthMed Psychiat1969;32:305–307.
J1992;85:146–147. 31. BickerstaffER,SmallJM,GuestIA.Therelapsingcourseofcertain
15. ChowWC,HoKH,FongCM.Intracranialmeningiomawithmetastaticbreast meningiomasinrelationtopregnancyandmenstruation.JNeurolNeurosurg
carcinoma.AnnOncol1992;3:409–410. Psychiat1958;21:89–91.
16. KnuckeyNW,StollJ,EpsteinMH.Intracranialandspinalmeningiomasin 32. OsborneCK,YochmowitzMG,KnightIIIWA,McGuireWL.Thevalueof
patientswithbreastcancinoma:casereports.Neurosurgery1989;25: estrogenandprogesteronereceptorsinthetreatmentofbreastcancer.Cancer
112–117. 1980;46(suppl12):2884–2888.
17. ZonLI,JohnsWD,StomperPC,KaplanWD,ConnollyJL,MorrisJHetal. 33. DonnellMS,MeyerGA,DoneganWL.Estrogenreceptorproteininintracranial
Breastcarcinomametastatictoameningioma.ArchInternMed1989;149: meningiomas.JNeurosurg1979;50:499–502.
959–962. 34. CahillDW,BashirelahiN,SolomonLW,DaltonT,SalcmanM,DucherTB.
18. JacobsDH,McFarlaneMJ,HolmesFF.Femalepatientswithmeningiomaof Estrogenandprogesteronereceptorsinmeningiomas.JNeurosurg1984;60:
thesphenoidridgeandadditionalprimaryneoplasmsofthebreastandgenital 985–993.
tract.Cancer1987;60:3080–3082. 35. MartuzaRL,MillerDC,MacLaughlinDT.Estrogenandprogestinbindingby
19. BarzH.Theincidenceofmetastaticcarcinomasinmeningiomas.EblAllg cytosolicandnuclearfractionsofhumanmeningiomas.JNeurosurg1985;62:
Pathol1983;127:367–374. 750–756.
20. LodriniS,SavoiardoM.Metastasesofcarcinomatointracranialmeningioma: 36. SchwartzMR,RandophRL,CechDA,RoseJE,PankoWB.Steroidhormone
reportoftwocasesandreviewoftheliterature.Cancer1981;48:2668–2673. bindingmacromoleculesinmeningiomas.Failuretomeetcriteriaofspecific
21. ChamberPW,DavisRL,BuckFS.Metastasestoprimaryintracranial receptors.Cancer1984;53:922–927.
meningiomasandneurilemomas.ArchPathLabMed1980;104:350–354. 37. PoissonM,MagdelenantH,FoncinJF,BleibelJM,PhilipponJ,PertuisetB
22. SavoiardoM,LodriniS.Hypodenseareawithinameningioma:metastasisfrom etal.R(cid:1)eecepteursD(cid:1)ooestrog(cid:1)eeneetdeprog(cid:1)eesteronedanslesmeningiomas.Etude
breastcancer.Neuroradiology1980;20:107–110. de22cas.RevNeurol1980;136:193–203.
23. P€ooyh€oonenL,HeikkinenJ,VehkalahtiI.Twodifferentprimarytumorsofthe 38. MaiuriF,MontagnaniS,GallicchisB.Estrogenandprogesteronereceptorsin
braininapatientwithbreastcancer.EurJNuclMed1979;4:483–484. meningiomas.SurgNeurol1986;26:430–435.
24. KepesJJ.Cellularwhorlsinbraintumorsotherthanmeningiomas.Cancer 39. GoldsherD,LittAW,PintoRS,BannonKR,KricheffII.Dural“tail”
1976;37:2232–2237. associatedwithmeningiomasonGd-DTPA-enhancedMRimages:
25. HaarF,PattersonRH.Surgeryformetastaticintracranialneoplasm.Cancer characteristics,differentialdiagnosticvalue,andpossibleimplicationsfor
1972;30:1241–1245. treatment.Radiology1990;176:447–450.
26. TheologidesA,LeeJC.Tumortotumormetastasis.JAMA1972;219:384. 40. KuboM,FukutomiT,Akashi-TanakaS,HasegawaT.Associationofbreast
27. AnlyanF,HeinzenBR,CarrasR.Metastasisoftumortoseconddifferent cancerwithmeningioma:reportofacaseandreviewoftheliterature.JpnJClin
tumors:collisiontumors.JAMA1970;212:2124. Oncol2001;31:510–513.
JournalofClinicalNeuroscience(2003)10(5),553–556 ª2003ElsevierScienceLtd.Allrightsreserved.
